The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies

Wang, Si-Yu (2022) The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies. [Dissertation (University of Nottingham only)]

[thumbnail of 20220942_BUSI4153_2021_22.pdf] PDF - Registered users only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (2MB)

Abstract

This paper extends the literature examining the association between board directors heterogeneity and firm innovation. Based on a collection of theories, such as upper echelons theory, and previous studies, the research employs a panel dataset comprising 1185 firm-year observations of 219 corporations in the Chinese pharmaceutical industry, covering 6 years from 2015 to 2020. R&D investment intensity is used as the measurement of a firm’s innovation level. The empirical findings suggest that functional background heterogeneity could significantly impede firms’ innovation performance and overseas background has a significantly positive relationship with R&D intensity. Besides, age, gender and educational background heterogeneity could also affect a corporation’s innovation level. The paper concludes by providing academic and practical recommendations on how to strengthen firms' innovation in the Chinese pharmaceutical industry. The research findings also provide opportunities and directions for future research.

Item Type: Dissertation (University of Nottingham only)
Depositing User: Wang, Siyu
Date Deposited: 25 Apr 2023 14:32
Last Modified: 25 Apr 2023 14:32
URI: https://eprints.nottingham.ac.uk/id/eprint/67743

Actions (Archive Staff Only)

Edit View Edit View